- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01304862
Electronic Self-management Resource Training for Mental Health (eSMART-MH)
February 11, 2022 updated by: Melissa D. Pinto-Foltz, Case Western Reserve University
The purpose of this study is to determine whether mental health treatment disengagement may be mitigated by reducing barriers to self-management and enhancing self-management skills.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Each year, more than four million young adults (age 18-25 years old) in the U.S. receive psychotropic medication or psychotherapy as treatment for a mental illness.
One in every four of these young adults will disengage from mental health treatment before significant symptom remission is achieved.
Mental health treatment disengagement may be mitigated by reducing barriers to self-management and enhancing self-management skills.
Electronic self-management resource training for mental health (eSMART-MH) is an innovative use of avatars-virtual persons who tailor responses to users-to improve mental health treatment disengagement.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- Frances Payne Bolton School of Nursing
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Self-report of a diagnosis depression or generalized anxiety disorder greater than six months
- Young adults 18-25 years of age
- Prescribed psychotropic medication and/or psychotherapy
- Have a documented domestic telephone number
- Able to read and understand English
Exclusion Criteria:
- Participation in the eSMART-HD parent project
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Self-management intervention
|
Involves simulated interactions between participants and the virtual health care providers (avatars).
|
|
Active Comparator: Educational Videos about Healthy Living
|
20 minute screen-based educational videos on topics about healthy living--nutrition, physical activity, and sleep hygiene.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Engagement in Mental Health Treatment: Medical Adherence Medication Module (MAMMM)
Time Frame: 12 weeks
|
Medical Adherence Measure Medication Module (MAMMM) is a 7-item scale that will determine the patient's degree of engagement and initiation of mental health treatment.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental Illness Stigma: Alienation Subscale
Time Frame: 12 weeks
|
A 6-item four point Likert type scale that asks participants to rate each item from 1 (strongly disagree) to 4 (strongly agree); a higher score indicates more mental illness stigma.
|
12 weeks
|
|
Mental Health Literacy: In Our Own Voice Knowledge Measure (IOOVKM)
Time Frame: 12 weeks
|
A 12-item scale that utilizes a 7-point Likert type scale with responses ranging from 1 (strongly disagree) to 7 (strongly agree).
Total scores range from 12-84, with a higher score indicating higher mental health literacy.
|
12 weeks
|
|
Patient Activation: Patient Activation Measure (PAM)
Time Frame: 12 weeks
|
13-item measure that assesses the patient's perception of their knowledge, skill, and confidence in self-management behavior.
Scores range from 0-100, with a higher score indicating greater patient activation.
|
12 weeks
|
|
Effective Communication: Patients' Self-Competence Subscale (PSC)
Time Frame: 12 weeks
|
A 16-item five point Likert scale that asks participants to rate items from 5 (important) to 1 (unimportant); a higher score indicates greater perceived self-competence and effective communication with a health care provider.
|
12 weeks
|
|
Symptom Severity: Hospital Anxiety and Depression Scale (HADS)
Time Frame: 12 weeks
|
A 14-item self-report measure that assesses anxiety and depression symptom severity.
The HADS contains separate subscales (7 items each) for depression and anxiety; items are scored on a four point scale from 0-4, and a summative score is generated for each subscale.
A cut score of 8 signifies an increased clinical risk for anxiety and depression.
|
12 weeks
|
|
Feasibility and Acceptability of Intervention
Time Frame: 12 weeks
|
To assess feasibility, the frequency of refusals and incidence of complete intervention doses will be documented.
Acceptability will be assessed by utilizing and adapted acceptability scale administered at the final time point.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Melissa D Pinto-Foltz, PhD, RN, Case Western Reserve University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
February 25, 2011
First Submitted That Met QC Criteria
February 25, 2011
First Posted (Estimate)
February 28, 2011
Study Record Updates
Last Update Posted (Actual)
March 2, 2022
Last Update Submitted That Met QC Criteria
February 11, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KL2RR024990 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on eSMART-MH intervention
-
Emory UniversitySusan G. Komen Breast Cancer FoundationWithdrawn
-
Emory UniversityWithdrawnDepression | HIV
-
VA Office of Research and DevelopmentCompletedPsychotic Disorders | Mood Disorders | Stress Disorders, Post-TraumaticUnited States
-
3-C Institute for Social DevelopmentNational Institute of Mental Health (NIMH)CompletedMental Health Strategies | School Mental Health Services | Digital Technologies | Technology DevelopmentUnited States
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH); New York City Department for the...Completed
-
Children's Hospital Medical Center, CincinnatiNational Institute of Mental Health (NIMH)RecruitingMental Health Disorder | Family Navigation | Minoritized Population | Preschool Age ChildrenUnited States
-
VA Office of Research and DevelopmentCompletedMental Health | Healthcare DisparitiesUnited States
-
Vespina Lifesciences Inc.Syneos Health; PrimeVigilance Ltd., UKCompleted
-
City University of New York, School of Public HealthHealthfirst; Harlem Congregation for Community Improvement, Inc.RecruitingDepression, Anxiety | Mental Health Wellness | Stress-related ProblemUnited States
-
Massachusetts General HospitalNational Institute on Minority Health and Health Disparities (NIMHD)CompletedMental DisordersUnited States, Puerto Rico